National Meeting highlights NIIMBL achievements, builds and expands the NIIMBL network, and sets the stage for future collaboration and innovation aimed to advance U.S. biomanufacturing.

The spirit of innovation, collaboration, and community was prevalent as NIIMBL convened its second National Meeting in Washington D.C. on May 16 and 17.

With an...

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), a proud member of Manufacturing USA®, is pleased to welcome Genentech, Celgene, Merck, MilliporeSigma and EMD Serono (the U.S. businesses of Merck KGaA, Darmstadt, Germany), among others, to its growing membership base.

These companies join more than 79...

The National Institute for Innovation in Manufacturing Biopharmaceuticals ( NIIMBL) is moving its headquarters into the University of Delaware’s new Biopharmaceutical Innovation Building, which is scheduled to open in 2020. NIIMBL participated in the groundbreaking ceremony for the building on Monday.

A rendering of the Biopharmaceutical...

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) and BioPhorum Operations Group (BPOG) and have entered into a collaboration agreement to develop a US-specific roadmap for the biopharmaceutical manufacturing industry. The roadmap will complement the existing BPOG global roadmap.

The US-specific Roadmap will focus...